CD38, A Target for Immunotherapeutic Approaches in Cancer
Cells | Free Full-Text | CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies
Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
CD38 - Wikipedia
Targeting CD38/CD3 brings breakthroughs in the immunotherapy of multiple myeloma - ACROBiosystems
Human CD38 Antibody MAB24041: R&D Systems
Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review
CD38 - Wikipedia
Pathology Outlines - CD38
Loss of CD38 antigen on CD34+CD38+ cells during short-term culture | Leukemia
Expression of the T cell activation markers HLA-DR and CD38 on peripheral T cells.
New Strategies for Targeting CD38 in Multiple Myeloma Take Root
Unraveling B cell trajectories at single cell resolution: Trends in Immunology
CD38 expression and function in NK cells. (A) Role of CD38 in the... | Download Scientific Diagram
Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
Cells | Free Full-Text | Roles of CD38 in the Immune Response to Infection
Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis - ScienceDirect
CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines - Sandoval‐Montes - 2005 - Journal of Leukocyte Biology -
CD20 and CD38 expression on normal and CLL B-cells. Cells were... | Download Scientific Diagram
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease | Nature Communications
CD38 and Regulation of the Immune Response Cells in Cancer
Cells | Free Full-Text | CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies
CD38 in the age of COVID-19: a medical perspective | Physiological Reviews
Clinical significance of CD38 and CD101 expression in PD‑1+CD8+ T cells in patients with epithelial ovarian cancer
International Clinical Cytometry Society
Alteration of Cell Surface Markers CD38 and CD138 in Lymphoproliferative Disorders in the Ocular Adnexa | Anticancer Research
Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
